This inventor holds 19 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Sumitomo Dainippon Pharma Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., Sumitomo Pharma Co., Ltd.. Active years: 2011-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Suita, JP (2011 - 2018)
- Osaka, JP (2014 - 2024)
Company Filing History:
9 out of 110 
5 out of 140 
4 out of 66 Years Active: 2011-2026
Areas of Expertise:
Title: Innovations and Contributions of Hidefumi Yoshinaga
Introduction: Hidefumi Yoshinaga, based in Osaka, Japan, is a notable inventor recognized for his significant contributions to the field of pharmaceuticals. With 18 patents to his name, Yoshinaga has focused his research on developing innovative compounds aimed at treating neuropsychiatric diseases.
Latest Patents: Among Hidefumi Yoshinaga's latest inventions are two notable patents. The first one, titled "Substituted Pyrazoles Showing Serotonin 5-HT Receptor Activity," relates to a medicament designed to treat neuropsychiatric diseases. This invention features a compound of Formula (1) or a pharmaceutically acceptable salt thereof as its active ingredient. The second patent, "Bicyclic Pyridine Derivative," provides a novel class of bicyclic pyridine derivatives, specifically a compound represented by formula I.
Career Highlights: Throughout his career, Yoshinaga has been affiliated with prominent companies in the pharmaceutical industry, such as Sumitomo Dainippon Pharma Co., Ltd. and Dainippon Sumitomo Pharma Co., Ltd. His work in these organizations has allowed him to advance his research and impact the development of new medications.
Collaborations: Collaboration has been essential to Yoshinaga's success in his field. He has worked alongside esteemed colleagues, including Tomohiro Toyoda and Izumi Sasaki, contributing to a team-oriented approach to innovation in pharmaceuticals.
Conclusion: In conclusion, Hidefumi Yoshinaga's contributions to medicine through his patents reflect his dedication to addressing complex health challenges. His innovative compounds and collaborative spirit continue to inspire advancements in neuropsychiatric treatments, marking him as a key figure in the pharmaceutical sector.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile